Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... disorder (PTLD). A 58-year-old man with myelodysplastic syndrome received allogeneic hematopoietic stemcelltransplantation from an unrelated donor after being conditioned ...
2009 NOV 17 ... South Korea, "We evaluate the outcomes in children with acute leukemia who received allogeneic hematopoietic stemcelltransplantation (HCT) using unrelated donor. Fifty-six children ...
2009 NOV 23 ... a young boy affected with this disease. ALD is currently treated with allogeneic bone marrow transplantation when there is an appropriate donor. Even so, the graft ... Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced the company's clinical program to treat Adrenoleukodystrophy (ALD). ... Genomics, Marketing and Licensing Agreements, Pharmaceuticals, Regulatory Actions, Stem Cell Research, Treatment, Genetix Pharmaceuticals. This article was prepared by ...
2009 NOV 16 ... Infectious Disease, "We describe a woman with relapsed acute myelogenous leukemia after allogeneic stem cell transplantation who developed disseminated Geotrichum candidum infection during chemotherapy-induced ...
2009 NOV 9 ... compared with a matched control group with LVEF of >= 50%, which received an allogeneic stem cell transplantation (allo-SCT). After a median follow-up of 29 months in the study group, grade >= 2 ...
2009 NOV 9 ... to the incidence and severity of HC clinical symptoms in HSCT patients among allogeneic transplantations, donor-recipient gender mismatches, bone marrow as a stemcell source, ... IVIg as antiviral drugs." Yaghobi and colleagues published their study in Transplantation Proceedings (The Role of Different Risk Factors in Clinical Presentation of Hemorrhagic ...
2009 NOV 16 ... for ES cell-based regenerative medicine, for the immunobiology of the embryo as a semi-allogeneic graft, and for the regenerative capacity of adult stem cells." Utermohlen ... their study in Biological Chemistry (Immunologic hurdles of therapeutic stem cell transplantation. Biological Chemistry, 2009;390(10):977-983). Additional information can be ...
2009 NOV 16 ... post-transplantation lymphoproliferative disease (PTLD) is a serious complication after allogeneic stem cell transplantation (SCT). The likelihood of PTLD is increased in the presence of specific risk factors." ...
2009 NOV 9 ... responses are relatively short, and the only potential curative treatment is allogeneic stem cell transplantation," wrote C.E. Dearden and colleagues, Royal Marsden Hospital. The ...
2009 NOV 16 ... bronchiolitis obliterans organizing pneumonia and nephrotic syndrome 5 months after allogeneic bone marrow transplantation from an unrelated donor for acute lymphoblastic leukemia," ... youngest case with nephrotic syndrome due to membranous nephropathy after hematopoietic stemcell transplantation." Motoyama and colleagues published their study in ...
2009 NOV 28 ... immediately before or at the timing of neutrophil engraftment following autologous or allogeneic SCT. It is characterized by fever, skin rash, and non-cardiac pulmonary ... in Pediatric Transplantation (Engraftment syndrome following allogeneic hematopoietic stemcelltransplantation in children. Pediatric Transplantation, ...
2009 NOV 9 ... in 'Natural killer cells--new understanding of basic biology may lead to more effective allogeneic haematopoietic stemcelltransplantation,' new data in life sciences. According to ...
2009 NOV 9 ... to receive iron chelation therapy. In addition, patients who are candidates for allogeneic stem cell transplantation might also benefit from chelation therapy because iron overload is associated with ...
2009 NOV 16 ... complications after receiving alemtuzumab as part of a conditioning regimen for allogeneic hematopoietic stemcelltransplantation (HSCT) in Korean patients. From November 2004 to ...
2009 NOV 16 ... relapse with involvement of the breasts by acute myeloid leukemia (AML) after allogeneic stem cell transplantation is an,uncommon event. We here report the case of a 27-year-old female patient, who was ...
2009 NOV 9 ... T-ALL have a poor outcome with chemotherapy alone (< 30%) and might profit from an allogeneictransplantation in first CR (OS > 50%). There seems to be no need for transplantation ... in T-LBL additional mediastinal irradiation seems to be beneficial. Strategies for stemcell transplantation (SCT) in T-LBL and T-ALL differ. Autologous SCT in complete ...
2009 NOV 9 ... in utero hematopoietic celltransplantation (IUHCT) in the murine model is reduced in allogeneic, compared with congenic, recipients." "This observation supports the ... i.e., fetal immunologic tolerance, is the most compelling rationale for prenatal stem cell and gene therapy. However, the frequency of engraftment following in utero ...
2009 NOV 9 ... Wroclaw, Poland, "Cytomegalovirus (CMV) reactivation was analyzed in 92 recipients of allogeneic hematopoietic stemcelltransplantation (HSCT) in relation to the proportion of CD4(+) ...
2009 NOV 9 ... previously untreated skin acute graft-versus-host disease (GVHD) within 100 days after allogeneic stem cell transplantation, and analyzed the relationship between types of infiltrating cells and clinical ...
